|
0
|
|
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Azizi M
…
Williams B
The Lancet
2026-03-07
|
#clinical trial
#pharmacotherapy
#hypertension
#aldosterone
|
|
0
|
|
Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study.
(linkinghub.elsevier.com)
|
Palomba ML
…
Morschhauser F
The Lancet
2026-03-07
|
#clinical trial
#immunotherapy
#lymphoma
#car-t cell therapy
|
|
0
|
|
Is it "time to eliminate" time to elimination of symptoms as a primary trial endpoint for respiratory virus targeting drugs?
(academic.oup.com)
|
Schiffer JT
…
Waghmare A
Journal of Infectious Diseases
2026-03-07
|
#infection
#clinical trial
#endpoint
#viral clearance
|
|
0
|
|
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial.
(linkinghub.elsevier.com)
|
Rivera S
…
Michiels S
The Lancet
2026-03-07
|
#clinical trial
#breast cancer
#radiotherapy
#lymphedema
|